Our Story

Quality and client satisfaction are our primary objectives. Primera facilitates scientist to scientist interaction and works collaboratively to ensure your analytical testing needs are fully satisfied. From top management and including all staff, Primera works diligently to ensure that all project time lines are met and high-quality data is produced. Our philosophy embraces the concept that a trustful relationship is the key to success. Building trust with our clients is of paramount importance to the future of our company.

In support of pharmaceutical and biopharmaceutical companies, Primera offers a broad array of analytical services such as method development, validation and transfer, stability, extractables and leachables, dissolution, and impurity studies.

Our bioanalytical division is highly experienced in GLP method development and validation for both small and large molecules, PK/PD studies, metabolite characterization, anti-drug antibody assays (ADA) and bioavailability and bioequivalence studies.

Our Biopharmaceutical Division is adept at development and validation of analytical methods (such as potency, purity, impurity, identity and characterization) for CMC of biologics and other drug modalities (peptides, oligonucletides and RNAs). Our biopharma unit also provides high quality services on cell line & cell banking.

Quality and client satisfaction are our primary objectives. Primera facilitates scientist to scientist interaction and works collaboratively to ensure your analytical testing needs are fully satisfied. From top management and including all staff, Primera works diligently to ensure that all project time lines are met and high-quality data is produced. Our philosophy embraces the concept that a trustful relationship is the key to success. Building trust with our clients is of paramount importance to the future of our company.

In support of pharmaceutical and biopharmaceutical companies, Primera offers a broad array of analytical services such as method development, validation and transfer, stability, extractables and leachables, dissolution, and impurity studies.

Our bioanalytical division is highly experienced in GLP method development and validation for both small and large molecules, PK/PD studies, metabolite characterization, anti-drug antibody assays (ADA) and bioavailability and bioequivalence studies.

Primera’s newest division, our biopharmaceutical group, is adept at bioassay method development and validation, impurities by ELISA, peptide mapping by LC/MS or LC/UV and carbohydrate analysis.

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.